2026 NLA Clinical Consensus: Updated LDL and ApoB Targets in Familial Hypercholesterolemia
Catherine Benziger, Medical Director of Heart and Vascular Research at Essentia Health, Adjunct Associate Professor of Medicine at the University of Minnesota Medical School, shared Christopher Cannon’s post on LinkedIn, adding:
“Check out the new LDL and ApoB targets for FH patients.”
Christopher Cannon, Cardiologist at Brigham and Women’s Hospital, Editor-in-Chief of Harvard Heart Letter, shared a post on LinkedIn about a recent article by Zahid Ahmad et al. published in JAMA:
“2026 NLA clinical consensus document on Familial Hypercholesterolemia.”
Title: Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association
Authors: Zahid Ahmad, Anandita Agarwala, Marina Cuchel, P. Barton Duell, Robert A. Hegele, Lisa Hudgins, Allison Jamison, Dinesh Kalra, Amit Khera, Joshua W. Knowles, Iftikhar Kullo, Ana Morales, Mark A. Rothstein, Joseph J. Saseen, Daniel Soffer, Bruce A. Warden, William S. Weintraub, Lauren Williams, Anne C. Goldberg
Read the Full Article on JAMA:
Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies